Millennium Management LLC 13D and 13G filings for Supernus Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-18 4:38 pm Purchase | 2026-02-11 | 13G | SUPERNUS PHARMACEUTICALS INC C SUPN | Millennium Management LLC | 3,281,615 5.700% | 245,492![]() (+8.09%) | Filing |
| 2026-02-02 4:33 pm Purchase | 2026-01-26 | 13G | SUPERNUS PHARMACEUTICALS INC C SUPN | Millennium Management LLC | 3,036,123 5.300% | 3,036,123![]() (New Position) | Filing |
